Phytoestrogens from Psoralea corylifolia reveal estrogen receptor-subtype selectivity

Phytomedicine

Volumn 17, Issue 2, 2010, Pages 126-131

  Xin, D ^a   Wang, H ^a   Yang, J ^a   Su, Y F ^a,b   Fan, G W ^a   Wang, Y F ^a   Zhu, Y ^a   Gao, X M ^a  

^a TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b TIANJIN UNIVERSITY   (China)

Author keywords

Estrogen receptor (ER); Luciferase; Phytoestrogen; Psoralea corylifolia

Indexed keywords

ACETIC ACID ETHYL ESTER; ANGELICIN; BAKUCHIOL; BAVACHIN; BUTANOL; CORYLIFOL A; COUMARIN DERIVATIVE; DICHLOROMETHANE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLAVONOID; FULVESTRANT; ISOBAVACHALCONE; NEOBAVAISOFLAVONE; PETROLEUM ETHER; PHYTOESTROGEN; PSORALEA CORYLIFOLIA EXTRACT; PSORALEN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CHROMATOGRAPHY; DRUG ACTIVITY; HELA CELL; HUMAN; HUMAN CELL; MEDICINAL PLANT; PRIORITY JOURNAL; PSORALEA CORYLIFOLIA; REPORTER GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; FICUSIN; FLAVONES; FLAVONOIDS; HELA CELLS; HUMANS; ISOFLAVONES; MEDICINE, CHINESE TRADITIONAL; PHENOLS; PHYTOESTROGENS; PLANT EXTRACTS; PSORALEA; PSORALENS; SEEDS; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

CULLEN CORYLIFOLIA;

EID: 73649107641     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.05.015     Document Type: Article

References (30)

1. Albertazzi P., and Purdie D. The nature and utility of the phytoestrogens: a review of the evidence. Maturitas 42 (2002) 173-185
2. Bhalla V.K., Nayak U.R., and Dev S. Some new flavonoids from Psoralea corylifolia. Tetrahedron Lett. 20 (1968) 2401-2406
3. Campbell-Thompson M., Lynch I.J., and Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ER beta isoforms in colon cancer. Cancer Res. 61 (2001) 632-640
4. Cassidy A. Potential tissue selectivity of dietary phytoestrogens and estrogens. Curr. Opin. Lipidol. 10 (1999) 47-52
5. Chen Y., Kong L.D., Xia X., Kung H.F., and Zhang L. Behavioral and biochemical studies of total furocoumarins from seeds of Psoralea corylifolia in the forced swimming test in mice. J. Ethnopharmacol. 96 (2005) 451-459
6. Davis S.R., Dalais F.S., Simpson E.R., and Murkies A.L. Phytoestrogens in health and disease. Recent Prog. Horm. Res. 54 (1999) 185-210
7. Fixemer T., Remberger K., and Bonkhoff H. Differential expression of the estrogen receptor beta (ER beta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma. Prostate 54 (2003) 79-87
8. Guo J.N., Weng X.C., Wu H., Li Q.H., and Bi K.S. Antioxidants from a Chinese medicinal herb-Psoralea corylifolia L. Food Chem. 91 (2005) 287-292
9. Kong L.D., Tan R.X., Woo A.Y.H., and Cheng C.H.K. Inhibition of rat brain monoamine oxidase activities by psoralen and isopsoralen: implications for the treatment of affective disorders. Basic Clin. Pharmacol. Toxicol. 88 (2001) 75-80
10. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., and Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93 (1996) 5925-5930
11. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg P., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 (1998) 4252-4263
12. Kuiper G.G., Shughrue P.J., Merchenthaler I., and Gustafsson J.A. The estrogen receptor beta subtype: a novel mediator of estrogen action in neuroendocrine systems. Front Neuroendocrinol. 19 (1998) 253-286
13. Latha P.G., Evans D.A., Panikkar K.R., and Jayavardhanan K.K. Immunomodulatory and antitumor properties of Psoralea corylifolia seeds. Fitoterapia 71 (2000) 223-231
14. Lim S.H., Ha T.Y., Kim S.R., Ahn J., Park H.J., and Kim S. Ethanol extract of Psoralea corylifolia L. and its main constituent, bakuchiol, reduce bone loss in ovariectomised Sprague-Dawley rats. Br. J. Nutr. 19 (2008) 1-9
15. Mar W., Je K.H., and Seo E.K. Cytotoxic Constituents of Psoralea corylifolia. Arch. Pharm. Res. 24 (2001) 211-213
16. Miksicek R.J. Estrogenic flavonoids: structural requirements for biological activity. Proc. Soc. Exp. Biol. Med. 208 (1995) 44-50
17. Pae H.O., Cho H., Oh G.S., Kim N.Y., Song E.K., Kim Y.C., Yun Y.G., Kang C.L., Kim J.D., Kim J.M., and Chung H.T. Bakuchiol from Psoralea corylifolia inhibits the expression of inducible nitric oxide synthase gene via the inactivation of nuclear transcription factor-k{cyrillic}B in RAW 264.7 macrophages. Int. Immunopharmacol. 1 (2001) 1849-1855
18. Paige L.A., Christensen D.J., Gron H., Norris J.D., Gottlin E.B., Padilla K.M., Chang C.Y., Ballas L.M., Hamilton P.T., Mcdonnell D.P., and Fowlkes D.M. Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc. Natl. Acad. Sci. USA 96 (1999) 3999-4004
19. Paruthiyil S., Parmar H., Kerekatte V., Cunha G.R., Firestone G.L., and Leitman D.C. Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res. 64 (2004) 423-428
20. Pettersson K., and Gustafsson J.A. Role of estrogen receptor beta in estrogen action. Annu. Rev. Physiol. 63 (2001) 165-192
21. Pistelli L., Spera K., Flamini G., Mele S., and Morelli I. Isoflavonoids and chalcones from Anthyllis hermanniae. Phytochemistry 42 (1996) 1455-1458
22. Shaaban A.M., O'Neill P.A., Davies M.P., Sibson R., West C.R., Smith P.H., and Foster C.S. Declining estrogen receptor-beta expression defines malignant progression of human breast neoplasia. Am. J. Surg. Pathol. 27 (2003) 1502-1512
23. Shou Q.Y., Yang R.P., Wang B.H., Liu J.Y., and Xu J.H. Study on the effective constituents with estrogenic action in Fructus Psoraleae traditional Chinese drug. Int. J. Clin. Pharmacol. Res. 18 (2007) 425-427
24. Sun N.J., Woo S.H., Cassady J.M., and Snapka R.M. DNA polymerase and topoisomerase II Inhibitors from Psoralea corylifolia. Nat. Prod. 61 (1998) 362-366
25. Wang D., Li F., and Jiang Z. Osteoblastic proliferation stimulating activity of Psoralea corylifolia extracts and two of its flavonoids. Planta Med. 67 (2001) 748-749
26. Xiong Z.L., Guo X.J., and Li F. Osteoblastic proliferative activity of extracts of Qing'e pill and its disassembled formulae. Pharm. Biol. 41 (2003) 434-438
27. Yin S., Fan C.Q., Dong L., and Yue J.M. Psoracorylifols A-E, five novel compounds with activity against Helicobacter pylori from seeds of Psoralea corylifolia. Tetrahedron 62 (2006) 2569-2575
28. Yin S., Fan C.Q., Wang Y., Dong L., and Yue J.M. Antibacterial prenylflavone derivatives from Psoralea corylifolia, and their structure-activity relationship study. Bioorg. Med. Chem. 12 (2004) 4387-4392
29. Zhang C.Z., Wang S.X., Zhang Y., Chen J.P., and Liang X.M. In vitro estrogenic activities of Chinese medicinal plants traditionally used for the management of menopausal symptoms. J. Ethnopharmacol. 98 (2005) 295-300
30. Zhao P.W., Wang D.W., Niu J.Z., Wang J.F., and Wang Q.L. Evaluation on phytoestrogen effects of ten kinds of Chinese medicine including floscarthami. Zhongguo Zhong Yao Za Zhi 32 (2007) 436-439